Alan Brochstein
shared:
1/24/2018 7:05:07 PM
ReplyLancet Publishes GW Pharma Epidiolex Phase 3 Clinical Trial Results for Treating Seizures https://t.co/FAzuvGje9M $GWPH #Epilepsy
— Alan Brochstein, CFA (@Invest420) January 25, 2018
